![David Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Liu
Corporate Officer/Principal chez
Harvard University
Fortune : 59 M $ au 31/07/2026
Profil
David R.
Liu is the founder of Ensemble Therapeutics Corp., founded in 2004, Permeon Biologics, Inc., founded in 2008, Editas Medicine, Inc., founded in 2013, and Exo Therapeutics, Inc., founded in 2018.
Dr. Liu is also the founder of nChroma Bio, Inc.,Prime Medicine, Inc.,Pairwise Plants Services, Inc...
Dr. Liu is currently a Professor at Harvard University.
Dr. Liu is currently an Associate Member at Massachusetts Institute of Technology.
Dr. Liu completed undergraduate education at Harvard University.
Dr. Liu earned a doctorate from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PRIME MEDICINE, INC. 11,73% | 31/03/2026 | 20 240 945 ( 11,73% ) | 59 M $ | 31/07/2026 |
Postes actifs de David Liu
| Sociétés | Poste | Début |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 06/09/2011 |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | 06/09/2011 |
Anciens postes connus de David Liu
| Sociétés | Poste | Fin |
|---|---|---|
| PRIME MEDICINE, INC. | Fondateur | - |
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes | Fondateur | - |
Pairwise Plants Services
 Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Engages in cultivation of crops | Fondateur | - |
| EDITAS MEDICINE, INC. | Fondateur | - |
Formation de David Liu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Ensemble Therapeutics Corp.
 Ensemble Therapeutics Corp. Chemicals: Major DiversifiedProcess Industries Develops novel classes of therapeutics and bioassays for research and diagnostics | Process Industries |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Permeon Biologics, Inc.
 Permeon Biologics, Inc. BiotechnologyHealth Technology Develops intracellular biotherapeutics platform to enhance drug delivery | Health Technology |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Pairwise Plants Services
Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Engages in cultivation of crops | Consumer Non-Durables |
Exo Therapeutics, Inc.
Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
